These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6858768)

  • 21. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Object naming and action-verb generation in Parkinson's disease: a fMRI study.
    Péran P; Cardebat D; Cherubini A; Piras F; Luccichenti G; Peppe A; Caltagirone C; Rascol O; Démonet JF; Sabatini U
    Cortex; 2009 Sep; 45(8):960-71. PubMed ID: 19368905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson's disease.
    Temel Y; Visser-Vandewalle V; Carpenter RH
    Exp Neurol; 2009 Apr; 216(2):481-9. PubMed ID: 19320006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease.
    Kamei S; Hara M; Serizawa K; Murakami M; Mizutani T; Ishiburo M; Kawahara R; Takagi Y; Ogawa K; Yoshihashi H; Shinbo S; Suzuki Y; Yamaguchi M; Morita A; Takeshita J; Hirayanagi K
    Mov Disord; 2008 Mar; 23(4):566-73. PubMed ID: 18098279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gait initiation in Parkinson's disease.
    Rosin R; Topka H; Dichgans J
    Mov Disord; 1997 Sep; 12(5):682-90. PubMed ID: 9380048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease.
    Lun V; Pullan N; Labelle N; Adams C; Suchowersky O
    Mov Disord; 2005 Aug; 20(8):971-5. PubMed ID: 15838853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for Parkinson's disease with response time batteries: a pilot study.
    Johnson AM; Vernon PA; Almeida QJ; Grantier LL; Singarayer R; Jog MS
    BMC Med Inform Decis Mak; 2004 Sep; 4():14. PubMed ID: 15361256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaction time and movement time after embryonic cell implantation in Parkinson disease.
    Gordon PH; Yu Q; Qualls C; Winfield H; Dillon S; Greene PE; Fahn S; Breeze RE; Freed CR; Pullman SL
    Arch Neurol; 2004 Jun; 61(6):858-61. PubMed ID: 15210522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Computerized method for arm movement assessment in Parkinson's disease and cerebellar syndrome patients].
    Dordević O; Popović MB; Kostić V
    Srp Arh Celok Lek; 2005; 133(1-2):14-20. PubMed ID: 16053170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the clinical heterogeneity of movement disorder in Parkinson disease].
    Liu ZL; Wang LM; Tao EX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):447-8. PubMed ID: 18359710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study.
    Herman T; Giladi N; Gruendlinger L; Hausdorff JM
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1154-8. PubMed ID: 17826461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson's disease.
    Sage MD; Almeida QJ
    Mov Disord; 2009 Jun; 24(8):1132-8. PubMed ID: 19373930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.
    Jenner P
    Mov Disord; 2008; 23 Suppl 3():S585-98. PubMed ID: 18781676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gait disorders of Parkinson's disease--'marche à petits pas', frozen gait and apraxia of gait].
    Ueno E
    No To Shinkei; 1991 Aug; 43(8):720-9. PubMed ID: 1931255
    [No Abstract]   [Full Text] [Related]  

  • 40. Computer-based assessment of movement difficulties in Parkinson's disease.
    Cunningham LM; Nugent CD; Moore G; Finlay DD; Craig D
    Comput Methods Biomech Biomed Engin; 2012; 15(10):1081-92. PubMed ID: 21604222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.